Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Letters to Relatives at Risk of Hereditary Cancer- a Multi-centre Randomised Controlled Trial of Healthcare-assisted Versus Family-mediated Risk Disclosure at Swedish Cancer Genetics Clinics (DIRECT-study)

NCT04197856 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT04197856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04197856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Letters to Relatives at Risk of Hereditary Cancer- a Multi-centre Randomised Controlled Trial of Healthcare-assisted Versus Family-mediated Risk Disclosure at Swedish Cancer Genetics Clinics (DIRECT-study)
Lead sponsor
Umeå University
Phase
Not applicable
Overall status
Unknown status
Start date
February 6, 2020
Completion date
July 1, 2025
Enrollment
490 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial breast cancer, familial colorectal cancer, hereditary breast and ovarian cancer syndrome, hereditary breast cancer, lynch syndrome